Workplace wellness programs can be effective win-wins for employees and
Report shows that pharmaceutical companies drive initiatives that boost
health through disease prevention and management, reaching over 1.1
million employees worldwide
GENEVA, Sept. 25, 2012 /CNW/ - Today the International Federation of
Pharmaceutical Manufacturers and Associations (IFPMA) released Health by the Numbers, a report detailing the 2011 results of the IFPMA Wellness Survey.
Through this assessment, IFPMA sought to document the extent to which
member companies engage in wellness programs, their scopes, and
contributions to employees' well-being.
The report also considers the role of workplace wellness programs in
addressing non-communicable diseases (NCDs). NCDs account for 63% of
worldwide deaths and can be reduced through changes to lifestyle
"Our companies have long recognized that improving employees' health is
a win-win: employees live longer, healthier lives and companies perform
better," said Eduardo Pisani, IFPMA Director General. "IFPMA companies
drive health initiatives that extend beyond the workplace. As most
people spend more waking hours at work than anywhere else, these
wellness programs are worthwhile, long-term endeavors."
The World Health Organization (WHO) has called on the private sector to
promote and support healthy workplaces. Health by the Numbers demonstrates how the 20 responding member companies have transformed
the workplace into platforms for healthy living, and includes the
following key findings:
85% focus on preventing or managing NCDs
65% were established before 2005
85% offer smoking-cessation support
50% focus on mental health prevention or support
70% conduct impact assessments
The 1-page "Infographic" of the report can be accessed here http://www.ifpma.org/fileadmin/content/Publication/2012/Health-By-The-Numbers_infographic.pdf.
The full report can be accessed here http://www.ifpma.org/fileadmin/content/Publication/2012/Health-By-The-Numbers_report.pdf.
World Health Organization. 2012. Annex to discussion paper 1: Effective
approaches for strengthening multisectoral action for NCDs. Available
About the IFPMA:
IFPMA represents the research-based pharmaceutical companies and
associations across the globe. The research-based pharmaceutical
industry's 1.3 million employees research, develop and provide
medicines and vaccines that improve the life of patients worldwide.
Based in Geneva, IFPMA has official relations with the United Nations
and contributes industry expertise to help the global health community
find solutions that improve global health.
For further information:
Peter Shelby, IFPMA, Tel +41/22-338-3223, Mob +41/79-820-2599, email@example.com; Ali Karami-Ruiz, IFPMA, Tel +41/22-338-3229, Mob +41/78-850-2903, firstname.lastname@example.org